Retinitis Pigmentosa (RP) functions as a degenerative disease that attacks the retina while causing vision deterioration until total blindness emerges in several patients. The widespread rare inherited eye disorder known as RP disrupts major life activities of those living with this condition. The traditional available treatment for RP involved symptom control and disease progression delay
The loss of vision causes severe life-altering problems. The effect of vision loss becomes severe because of three main groups of causes including age-related macular degeneration with retinal diseases and genetic conditions. The field of medical science provides new possibilities for treating eye vision loss that used to be managed through either symptom control or
Rod and cone dystrophy forms a collection of inherited retinal disorders that attack the rod and cone cells inside the retina. These special light-sensitive cells receive signals from the brain by picking up light energy. The eyesight loss from this condition becomes more severe until patients lose all light perception. Stem cell therapy provides new
The hereditary eye diseases which constitute retinal dystrophy reduce retina health through sustained degeneration that creates vision loss and may result in blindness. These genetic conditions produce the damage that current therapies struggle to counter or repair. The advancements in medical science through stem cell therapy bring new hope as a potential therapeutic solution to
A low light intensity vision loss also referred to as nyctalopia is a vision disorder wherein an individual struggles to see particularly at night. Night blindness is characterized by the ability of individuals to have a difficult time viewing items in poorly lit or during nighttime activities such as when driving during the night. Even
Optic Nerve Hypoplasia (ONH) is an infra orbital pathway that connects the eye to the brain through optic nerve which has been found to be affected by a disease. ONH persons have an abnormally developed optic nerve, and depending on the severity of the condition, the individual may experience partial or complete vision loss. The
Rod and cone dystrophy is a group of inherited diseases affecting the retina, the cells that are vital for vision. This condition results in gradual loss of vision. The patients have challenges seeing at night and eventually they become blind. We at Eyestemcellcenter believe firmly in our mission to constantly advance the stem cells treatment
Partial or complete vision loss dramatically impairs a person’s function, dependence, and, ultimately, the state of their health. Often it is a progressive process, which develops in the presence of various diseases affecting the retina, such as macular degeneration, diabetic retinopathy, glaucoma, or damage to the optic nerve. As with all of the symptoms, vision
Glaucoma optic atrophy is a severe eye pathology characterized by the destruction of optic nerve function and certain blinding impact. Stem cell treatment is one of the new regenerative therapies that impacts the eye by trying to rebuild optic nerve cells and regain some sight. Applications of Stem Cell Therapy in the Treatment of Glaucoma
For glaucoma optic atrophy, decision to undergo stem cell treatment involves selecting the best clinic. Specialized clinics have central importance for the patient’s safety, the effectiveness of the implemented treatment and further treatment monitoring. This needs to be explained to those considering stem cell therapy for glaucoma optic atrophy in London. Care and Cure: Specialist